Friday, August 28, 2015

Imodium recalled by Johnson & Johnson's McNeil Consumer Healthcare

McNeil Consumer Healthcare Thursday recalled one lot of Imodium Multi-Symptom Relief, an over-the-counter medicine for diarrhea, gas, bloating and cramps.

Imodium recalled by Johnson & Johnson's McNeil Consumer Healthcare

0 comments

McNeil Consumer Healthcare, the beleaguered Fort Washington drug maker, recalled more products on Thursday.

This time, McNeil recalled one lot of Imodium Multi-Symptom Relief, an over-the-counter medicine for diarrhea, gas, bloating and cramps.

The company said the 53,892 packages in that lot are likely still with wholesalers, so the recall is directed mainly to them. Some of the packages might be torn.

A company spokeswoman said McNeil has no safety concerns about the products in torn packages, but having been exposed to air, the medicine might not provide the intended benefits. She said the company had received no complaints from customers.

More coverage

The lot numbers are on the side of the box. The recalled lot number was CMF023.

The latest recall continues a troubling trend for the Johnson & Johnson division, which has its headquarters in Montgomery County, and has had dozens of recalls in the last few years.

Production at the Fort Washington facility stopped in April 2010 and it remains closed while undergoing $100 million in repairs and renovations. The closure was prompted by dozens of recalls that led the U.S. Food and Drug Administration to step in and a federal court judge to approve the plan to fix problems.

Company officials said earlier this year that repairs to the Fort Washington plant will run at least through the end of 2013, meaning products won’t leave the facility until sometime in 2014.

The Imodium recalled Thursday was produced at the McNeil plant in Lancaster.

The plants in Lancaster and Las Piedras, Puerto Rico, are operating under increased scrutiny because of the agreements with the government. It is unclear if this latest recall will affect the Lancaster plant production in the future.

McNeil produces well-known brands such as Tylenol and Motrin.

“We’re obviously disappointed that it is taking a little longer to get back into the market,” Johnson & Johnson chief financial officer Dominic Caruso said on a conference call with stock market analysts on April 17.

If consumers end up with one of the broken packages, they can call the company’s customer service line for help with a refund. That number is 1-888-222-6036 and is available Monday through Friday, 8 a.m. to 8 p.m. Eastern Time.

A link to the recall notice is here.

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com or 215-854-4506.

David Sell
Also on Philly.com:
letter icon Newsletter